Development and Validation of a Stability-Indicating Reverse Phase High-Performance Liquid Chromatography (RP-HPLC) Method for the Determination of Brivaracetam
International Journal of Drug Delivery Technology · 16.07.2026 · 16 (65s)
DOI: 10.25258/ijddt.16.65s.92 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Journal of Drug Delivery Technology, online erschienen am 16.07.2026. Verfasst von Yogini N. Rane und 2 weiteren Autor:innen.
Abstract (Originalsprache)
.
Zitieren
APA
Rane, Y. N., Gujar, S. V., & Sanaurrehman, M. (2026). Development and Validation of a Stability-Indicating Reverse Phase High-Performance Liquid Chromatography (RP-HPLC) Method for the Determination of Brivaracetam. International Journal of Drug Delivery Technology, 16(65s). https://doi.org/10.25258/ijddt.16.65s.92
Vancouver
Rane YN, Gujar SV, Sanaurrehman M. Development and Validation of a Stability-Indicating Reverse Phase High-Performance Liquid Chromatography (RP-HPLC) Method for the Determination of Brivaracetam. International Journal of Drug Delivery Technology. 2026;16(65s). doi:10.25258/ijddt.16.65s.92
BibTeX
@article{Rane2026,
author = {Rane, Yogini N. and Gujar, Shubham V. and Sanaurrehman, Momin},
title = {Development and Validation of a Stability-Indicating Reverse Phase High-Performance Liquid Chromatography (RP-HPLC) Method for the Determination of Brivaracetam},
journal = {International Journal of Drug Delivery Technology},
year = {2026},
volume = {16},
number = {65s},
doi = {10.25258/ijddt.16.65s.92}
}
EUVIMED